Skip to main content
SpringerLink
Log in

Hemostatic treatments

  • Conference paper
Portal Hypertension in the 21st Century

Abstract

Treatment of acute variceal bleeding should aim both at controlling bleeding and at preventing early rebleeding, which is particularly common within the first week and is associated with increased mortality1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D’Amico G, Pagliaro L, Bosch J. Pharmacologic treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19:475–505.

    Article  PubMed  Google Scholar 

  2. de Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis. 1999;19:439–55.

    Article  PubMed  Google Scholar 

  3. Moitinho E, Planas R, Bañares R et al. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol. 2001; 35:712–18.

    Article  PubMed  CAS  Google Scholar 

  4. Thabut D, de Franchis R, Bendtsen F et al. Efficacy of activated recombinant factor VIII (RFVIIa; Novoseven®) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial. J Hepatol. 2003;38(Suppl. 2):13 (abstract ).

    Article  Google Scholar 

  5. Merigan TC, Plotkin GR, Davidson CS. Effect of intravenously administered posterior pituitary extract on hemorrhage from bleeding esophageal varices. N Engl J Med. 1962; 266:134–5.

    Article  PubMed  Google Scholar 

  6. Cort J, Albrecht I, Novakova J, Mulder J, Jost K. Regional and systemic haemodynamic effects of some vasopressins: structural features of the hormone which prolong activity. Eur J Clin Invest. 1975;5:165–75.

    PubMed  CAS  Google Scholar 

  7. Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology. 1981;80:518–25.

    PubMed  CAS  Google Scholar 

  8. de Franchis R Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding oesophageal varices. Dig Liver Dis. 2004;36(Suppl. 1):S93–100.

    Article  PubMed  Google Scholar 

  9. Burroughs A, McCormick P, Hughes M, Sprengers D, D’Heygere F, McIntyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology. 1990;99:1388–95.

    PubMed  CAS  Google Scholar 

  10. Burroughs AK and the International Octreotide Varices Study Group. Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial/ failures. AASLD Abstracts. Hepatology. 1996;24:352A (abstract).

    Google Scholar 

  11. McKee R. A study of oct reo tide in oesophageal varices. Digestion. 1990;45:60–5.

    Article  PubMed  Google Scholar 

  12. Walker S, Kreichgauer H, Bode J. Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled double blind study. Hepatology. 1992;15:1023–30.

    Article  PubMed  CAS  Google Scholar 

  13. Pauwels A, Florent C, Desaint B, Guivarch P, Van H, Levy VG. Terlipressine et somatostatine dans le traitement des hemorragics par rupture de varices oesophagicnnes (Letter). Gastroenterol Clin Biol. 1994;18:388–9.

    PubMed  CAS  Google Scholar 

  14. Walker S, Kreigauer HP, Bode JC. Terlipressin versus somatostatin in the treatment of bleeding esophageal varices. Final report of a placebo-controlled, double blind study. Z Gastroenterol 1996;34:692–8.

    PubMed  CAS  Google Scholar 

  15. Feu F, Ruiz Del Arbol L, Banares R, Planas R, Bosch J. Double blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology. 1996;111:1291–9.

    Article  PubMed  CAS  Google Scholar 

  16. Silvain C, Carpentier S, Sautereau D et al. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology. 1993;18:61–5.

    PubMed  CAS  Google Scholar 

  17. Pedretti G, Elia G, Calzetti C, Magnani G, Fiaccadori F. Octreotide versus terlipressin in the acute variceal hemorrhage in cirrhosis. Emergency control and prevention of early rebleeding. Clin Invest. 1994;72:653–9.

    Article  CAS  Google Scholar 

  18. D’Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology. 2003;124:1277–91.

    Article  PubMed  Google Scholar 

  19. Stiegmann GV, Goff JS, Michaletz-Onody PA et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992;326:1527–32.

    Article  PubMed  CAS  Google Scholar 

  20. Laine L., El-Newihi HM, Migikowsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med. 1993;119:1–7.

    PubMed  CAS  Google Scholar 

  21. Gimson AES, Ramage JK, Panos MZ et al. Randomized trial of variceal banding ligation versus injection sclerotherapy for bleeding esophageal varices. Lancet. 1993;342:391–4.

    Article  PubMed  CAS  Google Scholar 

  22. Jensen DM, Kovacs TOG, Randall GM et al. Initial results of a randomized prospective study of emergency banding vs sclerotherapy for bleeding gastric or esophageal varices. Gastrointest Endosc. 1993;39:279 (abstract).

    Google Scholar 

  23. Lo GH, Lai KH, Cheng JS et al A prospective, randomized trial of injection sclerotherapy versus banding ligation in the management of bleeding esophageal varices. Hepatology. 1995;22:466–71.

    Article  PubMed  CAS  Google Scholar 

  24. Hou MC, Lin HC, Kuo BIT, Chen CH, Lee FY, Lee SD. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology. 1995;21:1517–22.

    PubMed  CAS  Google Scholar 

  25. Fakhry S, Omer M, Nouh A et al Endoscopic sclerotherapy versus endoscopic variceal ligation in the management of bleeding esophageal varices: a preliminary report of a prospective randomized study in schistosomal hepatic fibrosis. Hepatology. 1995;22:251A (abstract).

    Google Scholar 

  26. Sarin SK, Goyal A. Jain A, Guptan RC, Murthy MS. Randomized prospective trial of endoscopic sclerotherapy vs variceal ligation for bleeding esophageal varices: influence on gastropathy, gastric varices and recurrences. J Hepatol. 1997;26:826–32.

    Article  PubMed  CAS  Google Scholar 

  27. Lo GH, Lai KH, Cheng JS et al. Emergency banding ligation vs. sclerotherapy for the control of active bleeding from esophageal varices. Hepatology. 1997;25:1101–4.

    Article  PubMed  CAS  Google Scholar 

  28. Levacher S, Letoumelin PH, Paternon D, Blaise M, Lepandry C, Pourriat JL. Early administration of terlipressin plus glyceryltrinitrate for active upper gastrointestinal hemorrhage in cirrhotic patients. Lancet. 1995;346:865–8.

    Article  PubMed  CAS  Google Scholar 

  29. Besson I, Ingrand P, Person B et al Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med. 1995;333:555–60.

    Article  PubMed  CAS  Google Scholar 

  30. Sung JJ, Chung SCS, Yung MY et al. Prospective randomised study of effect of octreotide on rebleeding from esophageal varices after endoscopic ligation. Lancet. 1995;346:1666–9.

    Article  PubMed  CAS  Google Scholar 

  31. Signorelli S, Negrini F, Paris B, Bonelli M, Girola M. Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal hemorrhage: our experience. Gastroenterology. 1996;110(SuppL) A1326 (abstract).

    Google Scholar 

  32. Brunati S, Ceriani R, Curioni R, Brunelli L, Repaci G, Morini L. Sclerotherapy alone vs. sclerotherapy plus terlipressin vs. sclerotherapy plus octreotide in the treatment of acute variceal hemorrhage. Hepatology. 1996;24(Supp.1):207A (abstract).

    Google Scholar 

  33. Burroughs AK. Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial failures. Hepatology. 1996;24(Suppl.):352A (abstract).

    Google Scholar 

  34. Signorelli S, Paris B, Negrin F, Bonelli M, Auriemma M. Esophageal varices bleeding: comparison between treatment with sclerotherapy alone vs. sclerotherapy plus octreotide. Hepatology. 1997;26(Suppl.):137A (abstract).

    Google Scholar 

  35. Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet. 1997;350:1495–9.

    Article  PubMed  CAS  Google Scholar 

  36. Zuberi BF, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis. Am J Gastroenterol. 2000;95:768–71.

    Article  PubMed  CAS  Google Scholar 

  37. Calés P, Masliah C, Bernard B et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med. 2001;344:23–8.

    Article  PubMed  Google Scholar 

  38. Villanueva C, Ortiz J, Sàbat M et al. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology. 1999;30:384–9.

    Article  PubMed  CAS  Google Scholar 

  39. Novella MT, Villanueva C, Ortiz J et al. Octreotide vs. sclerotherapy and octreotide for acute variceal bleeding: a pilot study. Hepatology. 1996;24(Suppl.):207A (abstract).

    Google Scholar 

  40. Bañares R, Albillos A, Rincon D et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology. 2002;35: 609–15.

    Article  PubMed  Google Scholar 

  41. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33:846–52.

    Article  PubMed  Google Scholar 

  42. D’Amico G, de Franchis R and a cooperative study group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38: 599–612.

    Article  PubMed  Google Scholar 

  43. Escorsell A, Bordas JM, Ruiz del Arbol L et al. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. J Hepatol 1998;29:779–88.

    Article  PubMed  CAS  Google Scholar 

  44. Ejlersen E, Melsen T, Ingerslev J, Andreasen RB, Vilstrup H. Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol. 2001;36:1081–5.

    Article  PubMed  CAS  Google Scholar 

  45. Romero-Castro R, Jimenez-Saenz M, Pellicer-Bautista F et al. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices. Clin Gastroenterol Hepatol. 2004;2:78–84.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine Gastroenterology and Gastrointestinal Endoscopy Service, University of Milan IRCCS Ospedale Maggiore, Via Pace 9, 20122, Milan, Italy

    Roberto De Franchis

Authors
  1. Roberto De Franchis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Yale University School of Medicine, New Haven, CT, USA

    R. J. Groszmann

  2. Hepatic Hemodynamic Laboratory Liver Unit, Hospital Clinic, University of Barcelona, Spain

    J. Bosch

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media Dordrecht

About this paper

Cite this paper

De Franchis, R. (2004). Hemostatic treatments. In: Groszmann, R.J., Bosch, J. (eds) Portal Hypertension in the 21st Century. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1042-9_26

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-1042-9_26

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-3774-7

  • Online ISBN: 978-94-007-1042-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation